Filter Results
:
(4,495)
Show Results For
-
All HBS Web
(4,495)
- People (14)
- News (1,511)
- Research (2,208)
- Events (1)
- Multimedia (152)
- Faculty Publications (1,734)
Show Results For
-
All HBS Web
(4,495)
- People (14)
- News (1,511)
- Research (2,208)
- Events (1)
- Multimedia (152)
- Faculty Publications (1,734)
- August 2020 (Revised January 2022)
- Case
1928 Diagnostics: Fighting Antibiotics Resistance
By: Ariel D. Stern and Daniela Beyersdorfer
In 2019, the co-founders of the Swedish medical start-up 1928 Diagnostics, CEO Dr. Kristina Lagerstedt and COO Dr. Susanne Staaf, had to pick the right business model to commercialize their novel technology to hospitals and health care providers. Developed in...
View Details
Keywords:
Health Care and Treatment;
Entrepreneurship;
Leadership;
Science-Based Business;
Growth and Development Strategy;
Business Growth and Maturation;
Business Model;
Information Technology;
Digital Platforms;
Health Disorders;
Market Entry and Exit;
Value Creation;
Business and Stakeholder Relations;
Health Industry;
Health Industry;
Health Industry;
Europe;
Sweden
Stern, Ariel D., and Daniela Beyersdorfer. "1928 Diagnostics: Fighting Antibiotics Resistance." Harvard Business School Case 621-025, August 2020. (Revised January 2022.)
- February 2009
- Article
Goals Gone Wild: The Systematic Side Effects of Over-Prescribing Goal Setting
By: Lisa D. Ordonez, Maurice E. Schweitzer, Adam D. Galinsky and Max H. Bazerman
Goal setting is one of the most replicated and influential paradigms in the management literature. Hundreds of studies conducted in numerous countries and contexts have consistently demonstrated that setting specific, challenging goals can powerfully drive behavior and...
View Details
Keywords:
Goals and Objectives;
Management Practices and Processes;
Organizational Culture;
Performance Improvement;
Behavior;
Motivation and Incentives
Ordonez, Lisa D., Maurice E. Schweitzer, Adam D. Galinsky, and Max H. Bazerman. "Goals Gone Wild: The Systematic Side Effects of Over-Prescribing Goal Setting." Academy of Management Perspectives 23, no. 1 (February 2009).
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Care and Treatment;
Technology Adoption;
Technological Innovation;
Safety;
Medical Devices and Supplies Industry;
United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- 20 Jul 2010
- First Look
First Look: July 20
case:http://cb.hbsp.harvard.edu/cb/product/710054-PDF-ENG Jiamei Dental: Private Health Care in China William C. Kirby and G.A. DonovanHarvard Business School Case 910-404 With...
View Details
Keywords:
Martha Lagace
- Research Summary
Overview
By: Michael Chu
Chu's research is focused on business and low income sectors, particularly in the use of commercial platforms to deliver what has traditionally been considered public responsibilities. In the last three decades, business models have emerged to meet the underserved...
View Details
Keywords:
Impact Investing;
Microfinance;
Base Of The Pyramid;
Role Of Profit And Social Impact;
Private Sector Development;
Emerging Markets;
Business Ventures;
Health Care and Treatment;
Management;
Social Enterprise;
Strategy;
Health Industry;
Health Industry;
Health Industry;
Latin America;
North and Central America;
Asia;
Africa
- April 2012 (Revised February 2013)
- Case
Learning About Reducing Hospital Mortality at Kaiser Permanente
By: Anita Tucker
In 2011, Kaiser Permanente Northern California (KPNC) region's efforts to reduce mortality in their 21 hospitals is showing promise. They developed and launched a region-wide initiative to improve the treatment of sepsis, a serious and often deadly medical condition....
View Details
Keywords:
Change Management;
Health Care and Treatment;
Performance Improvement;
Health Industry;
California
Tucker, Anita. "Learning About Reducing Hospital Mortality at Kaiser Permanente ." Harvard Business School Case 612-093, April 2012. (Revised February 2013.)
- October 2006 (Revised January 2008)
- Case
Clinical Change at Intermountain Healthcare
By: Richard M.J. Bohmer and Erika Ferlins
Provides a detailed description of the way in which several improvements and innovations in clinical care were arrived at. Describes individual insights, how these were evaluated and validated, and how they were translated into improved medical practices. The changes...
View Details
Keywords:
Health Care and Treatment;
Innovation and Invention;
Business Processes;
Performance Improvement;
Practice;
Health Industry
Bohmer, Richard M.J., and Erika Ferlins. "Clinical Change at Intermountain Healthcare." Harvard Business School Case 607-023, October 2006. (Revised January 2008.)
- October 2023
- Case
Hey Jane: Delivering Abortion Pills to the Doorstep
By: Rembrand Koning, Geraldine Pena-Galea and Sarah Mehta
This case tells the story of Hey Jane, a telehealth clinic founded in 2020 that provides virtual medication abortion services to eligible patients in nine U.S. states. By January 2023, the company had served more than 20,000 patients and raised nearly $10 million in...
View Details
Keywords:
Operations;
Business Startups;
Health Care and Treatment;
Growth and Development Strategy;
Health Industry;
Health Industry;
United States
Koning, Rembrand, Geraldine Pena-Galea, and Sarah Mehta. "Hey Jane: Delivering Abortion Pills to the Doorstep." Harvard Business School Case 724-408, October 2023.
- February 1999 (Revised March 2000)
- Background Note
Changing Physician Behavior
By: Richard M.J. Bohmer
A review of strategies to change physician behavior including feedback, profiling, consensus-based guidelines, care paths, and computer systems. Discusses the strengths and weaknesses of each observation.
View Details
Bohmer, Richard M.J. "Changing Physician Behavior." Harvard Business School Background Note 699-124, February 1999. (Revised March 2000.)
- 29 Oct 2020
- Research & Ideas
The COVID Gender Gap: Why Fewer Women Are Dying
While all of these countries are part of the Organisation for Economic Co-operation and Development and all have high income per capita and advanced View Details
Rational Habit Formation
Regular handwashing with soap is believed to have substantial impacts on child health in the developing world. Most handwashing campaigns have failed, however, to establish and maintain a regular practice of handwashing. Motivated by scholarship that suggests... View Details
- Dec 04 2019
- Interview
Good Management Can Save Your Life
- 13 Jul 2016
- News
The high price of workplace stress
Incentives for Bad Science
Randomized controlled trials (RCTs) inform medical practice, health care delivery, follow-on research, regulation, and health policy. Yet, many RCTs are inadequately randomized, blinded, and reported. To analyze scientists' and firms' incentives to meet clinical trial...
View Details